TGF-beta isoforms fail to modulate inositol phosphates and cAMP in normal and tumour-derived human oral keratinocytes.

[1]  H. Moses,et al.  Transforming Growth Factor β and Cell Cycle Regulation , 1995 .

[2]  S. Winawer,et al.  Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells. , 1994, The Journal of biological chemistry.

[3]  W. A. Yeudall,et al.  TGF‐β receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytes , 1994, International Journal of Cancer.

[4]  F. Watt,et al.  Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinomas. , 1993, Carcinogenesis.

[5]  S. Lanier,et al.  Signaling events initiated by transforming growth factor-beta 1 that require Gi alpha 1. , 1993, The Journal of biological chemistry.

[6]  J. Dumont,et al.  General inhibition by transforming growth factor β1 of thyrotropin and cAMP responses in human thyroid cells in primary culture , 1993, Molecular and Cellular Endocrinology.

[7]  R. Derynck,et al.  Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. , 1993, Science.

[8]  N. Fusenig,et al.  Progressive abrogation of TGF‐β‐1 and EGF growth control is associated with tumour progression in ras‐transfected human keratinocytes , 1992, International journal of cancer.

[9]  S. Chakrabarty Role of protein kinase C in transforming growth factor‐β1 induction of carcinoembryonic antigen in human colon carcinoma cells , 1992 .

[10]  K. M. Mulder,et al.  Activation of p21ras by transforming growth factor beta in epithelial cells. , 1992, The Journal of biological chemistry.

[11]  R. Weinberg,et al.  Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase , 1992, Cell.

[12]  P. Galéra,et al.  TGF‐β–induced G2/M delay in proliferating rabbit articular chondrocytes is associated with an enhancement of replication rate and a cAMP decrease: Possible involvement of pertussis toxin‐sensitive pathway , 1992 .

[13]  Anita B. Roberts,et al.  Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.

[14]  N. Maitland,et al.  The behaviour of human oral squamous cell carcinoma in cell culture , 1990, The Journal of pathology.

[15]  P. Howe,et al.  Inhibition of mink lung epithelial cell proliferation by transforming growth factor-beta is coupled through a pertussis-toxin-sensitive substrate. , 1990, The Biochemical journal.

[16]  P. Howe,et al.  Transforming growth factor beta 1 treatment of AKR-2B cells is coupled through a pertussis-toxin-sensitive G-protein(s). , 1989, The Biochemical journal.

[17]  B. Magun,et al.  Transforming Growth Factor @ and Epidermal Growth Factor Alter Calcium Influx and Phosphatidylinositol Turnover in Rat- 1 Fibroblasts* , 2001 .

[18]  L. Matrisian,et al.  Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA. , 1988, The Journal of biological chemistry.

[19]  S. Yuspa,et al.  Early signals for keratinocyte differentiation: role of Ca2+-mediated inositol lipid metabolism in normal and neoplastic epidermal cells. , 1988, Carcinogenesis.

[20]  J. Stadel,et al.  Coupling of TGF-β-induced mitogenesis to G-protein activation in AKR-2B cells , 1988 .

[21]  B. Magun,et al.  Transforming growth factor beta modulates epidermal growth factor-induced phosphoinositide metabolism and intracellular calcium levels. , 1988, The Journal of biological chemistry.

[22]  J. Pouysségur,et al.  TGF‐β inhibits growth factor‐induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events , 1988 .

[23]  P. Hawkins,et al.  Inositol 1,3,4,5-tetrakisphosphate and not phosphatidylinositol 3,4-bisphosphate is the probable precursor of inositol 1,3,4-trisphosphate in agonist-stimulated parotid gland. , 1986, The Biochemical journal.